Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS welcomes the class of 2010
2010-01-13

Pictured with Prof Jansen are, from the left: Christo Smal (B.Sc. Quantity Surveying student from Bloemfontein), Nicole Tarentaal (LL.B. student from Bloemfontein), Charmoné Swartz (LL.B. student from Kimberley) and Lizé de Witt (B.Sc. Quantity Surveying student from Bloemfontein).
Photo: Stephen Collett


The University of the Free State (UFS) welcomed its first-time entering first-year students on the Main Campus in Bloemfontein this past weekend.

Addressing the new students and their parents at the ceremony, the Rector and Vice-Chancellor Prof. Jonathan Jansen assured the new students and their parents that “they are at the right place”.

“We will not cut corners with your child’s education as we are serious about the quality of the education we provide,” he said to the parents. “We shall make sure that our students are distinguished among graduates from other universities – that they are leaders. Quality is not negotiable.”

Prof. Jansen also said the standards of admission at the UFS would be raised. “We need students of a higher academic standard,” he said.

“Our students will obtain a degree they will be proud of. We are going to put everything into their education and experience here at the UFS so that they can be the best in their field of study.”

He told the new students and their parents that they were safe at the UFS as no first-year student would be initiated anymore. He said that there were other ways to create self-respect and confidence in a young person without having to use initiation.

“It is not enough to have a degree,” he said. “We want to link your degree to thorough preparation for the workplace. Your degree must be accepted globally.”

Prof. Jansen further emphasised the importance of students to understand one another and to get along with one another – especially with those who speak a language different from their own and with a different skin colour than theirs.

“Our students must have respect for one another. This is a value that should be added to your qualification in order for you to be relevant in the workplace anywhere in the world.”

He said the university was busy with a programme to install computer points in all the residences. He also extolled the virtues of the UFS, citing excellence in sport, music, debating and other activities.

Prof. Jansen also reiterated the fact that the first group of 100 first-year students who would be sent overseas to study during the second semester would come from this class of 2010.

“The class of 2010 will change Kovsies. They will be the best students that have ever graduated,” he said.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
12 January 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept